Vaccines in schools: there are two trials in progress in children and adolescents, both in the home straight. "Some preliminary results are coming and there are grounds to hypothesize that their authorization by the regulatory activities may arrive in time for the reopening of the schools." This was stated by the immunologist Sergio Abrignani, of theState University of Milan as well as a member of the technical-scientific committee. Both vaccines that are being tested in children and adolescents are based on the messenger RNA technique and the companies are conducting the studies. Moderna and Pfizer / Biontech.
“It is possible that in both cases the approval by the regulatory authorities is quick enough, in time for the reopening of the schools. The vaccination campaign has now taken off and it is likely that in September we will have 85 percent of the population vaccinated ”. These are the rather optimistic perspectives of the immunologist. The expert also points out that 10 percent of the population refuses the vaccine and then there is about 5 percent who cannot get vaccinated for other reasons. By virtue of this, a September, about 7 million children and young people aged 2 to 18 could remain to be vaccinated.
Vaccines in schools: the ongoing trials
The first phase 2/3 trial, conducted by Moderna, began in United States in December 2020 on 3 thousand children between 12 and 17 years. In addition, the same company has just started a second study, called KidCove, also in phase 2/3 on 6.750 children from six months to 11 years. According to the plans, the first to receive the vaccine will be the older ones and gradually it will move to the smallest ones.
In the United States and in Germany the experimentation conducted by Pfizer / Biontech on 2.260 children between the ages of 12 and 15. In light of the positive results obtained, the company is preparing to submit the request for authorization to the regulatory authorities of the United States (Fda) and Europe (Ema). The forecast is that the vaccine may be available as early as June. The data indicate that, after both doses, the production of the major antibody levels occurred in the age group between 16 and 25 years.
Today's data
Meanwhile, experts and health professionals constantly monitor the contagion curve which continues to record a decidedly decreasing trend. In fact, according to data from the Ministry of Health, the new positive cases recorded in the last 24 hours in Italy are 5.948 (yesterday 9.148). The new deaths are 256 (yesterday 144). Overall, the currently positive subjects are 423.558, 7.348 cheaper than yesterday. the discharged healed in the last 24 hours are 13.038 (yesterday 8.637). The swabs carried out are 121.829 (yesterday 156.872); in intensive care Covid patients are 2490 (yesterday 2.524) still remain in home isolation 402.673 people infected with Coronavirus. (yesterday 410.037).
